Contribution of Pancreatic αcells Function to Blood Glucose Regulation in Chinese Type 2 Diabetics- the Effect of Sitagliptin on Glucagon Secretion, Insulin Secretion and Insulin Resistance in Chinese Type 2 Diabetics

Clinical trial NCT01610154 · COMPLETED

Trial details

NCT number: NCT01610154
Sponsor: Guangwei Li
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Insulin Secretion Insulin Resistance

Start date: 2012-10-01
Primary completion: 2014-08-01
Enrollment: 85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.